OCUL OCULAR THERAPEUTIX INC
FollowCOM (common), issuer CIK 1393434
Filings received so far for Q3 2026: 5 13F filers report a position in OCUL shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Kaiser Peterofficer (Chief Development Officer) | 2026-10-02 | -9,990 S | $7.05 | Form 4 |
| Heier Jeffrey S.officer (Chief Scientific Officer) | 2026-10-02 | -10,869 S | $7.05 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| FINANCIAL MANAGEMENT NETWORK INC | 22,000 | $153K | 0.02% | 0 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 2,012 | $15.4K | <0.01% | +483 | 13F-HRTimeline |
| GAMMA Investing LLC | 1,916 | $14.7K | <0.01% | +433 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 735 | $5.64K | <0.01% | -25 | 13F-HRTimeline |
| Versant Capital Management, Inc | 435 | $3.34K | <0.01% | +76 | 13F-HRTimeline |
Events
Kaiser Peter sold 9,990 OCUL shares on 2026-10-02, Form 4 filed 2026-10-06. 0001104659-26-114081
Accepted , ingestedHeier Jeffrey S. sold 10,869 OCUL shares on 2026-10-02, Form 4 filed 2026-10-06. 0001104659-26-114080
Accepted , ingested